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Background: Recently, a real-time PCR assay known as photo-induced electron transfer (PET)-PCR which relies on
self-quenching primers for the detection of Plasmodium spp. and Plasmodium falciparum was described. PET-PCR
assay was found to be robust, and easier to use when compared to currently available real-time PCR methods. The
potential of PET-PCR for molecular detection of malaria parasites in a nationwide malaria community survey in Haiti
was investigated.
Methods: DNA from the dried blood spots was extracted using QIAGEN methodology. All 2,989 samples were
screened using the PET-PCR assay in duplicate. Samples with a cycle threshold (CT) of 40 or less were scored as
positive. A subset of the total samples (534) was retested using a nested PCR assay for confirmation. In addition,
these same samples were also tested using a TaqMan-based real-time PCR assay.
Results: A total of 12 out of the 2,989 samples screened (0.4%) were found to be positive by PET-PCR (mean CT
value of 35.7). These same samples were also found to be positive by the nested and TaqMan-based methods.
The nested PCR detected an additional positive sample in a subset of 534 samples that was not detected by
either PET-PCR or TaqMan-based PCR method.
Conclusion: While the nested PCR was found to be slightly more sensitive than the PET-PCR, it is not ideal for high
throughput screening of samples. Given the ease of use and lower cost than the nested PCR, the PET-PCR provides
an alternative assay for the rapid screening of a large number of samples in laboratory settings.
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The prevalence and distribution of malaria infection in a
country is an integral indicator for national malaria con-
trol programmes, which can be used to measure the
success of intervention strategies and for appropriate re-
source allocation. Therefore, an accurate and sensitive
measurement of malaria parasite prevalence is crucial.
Many studies have relied on the use of microscopy and
rapid diagnostic tests (RDTs) for the detection of malaria
parasites during epidemiological surveillance studies.* Correspondence: NLucchi@cdc.gov
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unless otherwise stated.The use of RDTs for malaria diagnosis increased after
the World Health Organization (WHO)’s recommenda-
tion to treatment only after a parasitological diagnosis
[1] RDTs are easy to use, do not require electricity or in-
tense expertise and provide results that can be used to
make treatment decisions [2]. However, neither micros-
copy nor RDTs are able to detect low density parasite
infections [3,4] and (reviewed in [5]) which are often
asymptomatic [6-8]. Studies have demonstrated that
asymptomatic malaria infections can serve as transmis-
sion foci in both low and high transmission settings and,
therefore, remain as sources of new infections [9-13]. It
is imperative for malaria elimination programmes toLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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whether symptomatic or asymptomatic [7].
Nucleic acid amplification tests (molecular tests),
such as PCR-based assays, have both, superior sensitiv-
ity and specificity compared to microscopy and RDTs,
detecting parasitaemia counts as low as 1 parasite/μL
(reviewed in [5]). Epidemiological studies that have
incorporated molecular testing show that the preva-
lence of malaria parasites is often underestimated
when only microscopy and RDTs are utilized for para-
site detection [10,11,14-16]. However, some challenges
exist that slow/impede the implementation of molecu-
lar assays in large epidemiological surveillance studies.
These include the cost and the ease of performance of
molecular tests. An ideal molecular assay needs to be
amenable to the screening of a large number of sam-
ples quickly and easily, as well as be cost efficient. Due
to shorter assay preparation and analysis time, real-
time PCR assays are better suited for large-scale stud-
ies than conventional nested 18S rRNA PCR assays. In
addition, the cost of many of these assays is declining
as reduced reaction volumes can be successfully
utilized [17] and less expensive primer/fluorophore
design utilized. One such test is the multiplexed
photo-induced electron transfer (PET)-PCR which was
shown to be as robust and cost-effective compared to
the nested PCR [18].
Endemic malaria transmission in the Caribbean region
is restricted to the island of Hispaniola: Haiti and the
Dominican Republic being the two nations that share
this island. A large proportion of malaria cases in His-
paniola is contributed by Haiti where 25,423 confirmed
malaria cases were reported in 2012 [19]. However, ac-
curate surveillance data from Haiti are still limited. Haiti
is among the 15 countries in the Americas that are in
the malaria control phase, although efforts are being
mobilized to steer Hispaniola towards malaria elimin-
ation [20]. Malaria RDTs and microscopy are not always
capable of detecting low parasite densities infections.
Therefore, to achieve the goal of malaria elimination,
more sensitive detection assays will need to be incorpo-
rated into the routine surveillance activities. To date,
only one study has utilized a molecular assay to estimate
the prevalence of Plasmodium falciparum infection
in Haiti [16]. This population-based survey utilized a
nested PCR assay to test a total of 714 samples obtained
from the Artibonite Valley during a high malaria trans-
mission season. Their study demonstrated higher preva-
lence of malaria by nested PCR (3.1%) than determined
by microscopy (0.9%) [16]. Herein, the utility of the
PET-PCR for use in a national community survey using
samples collected in nationwide population-based sur-
veys conducted to estimate malaria prevalence in Haiti
was evaluated.Methods
Ethical considerations
The survey protocol was approved by the Haiti ethical
review committee. Centers for Disease Control and
Prevention (CDC) investigators provided technical advice
and participated without engagement, based on not having
direct contact with study participants or access to any per-
sonally identifiable information.
Survey and specimen collection
In November-December 2011, during peak malaria trans-
mission season, a national population-based community
survey was conducted by Population Services International
(PSI), Haiti, in collaboration with the Haitian national mal-
aria control programme (PNCM, per its acronym in
French), and the National Public Health Laboratory (LNSP,
per its acronym in French). This survey utilized a cross-
sectional, two-stage, cluster design where census enumer-
ation areas (EAs) were selected from each of Haiti’s ten
departments, with a probability proportionate to size.
Within each sampled EA, all households were listed, a sam-
pling interval was determined, and 20 households were ran-
domly selected using systematic sampling. Questionnaires
were conducted with the head of the household, and all
household members present on the day (total of 3,944) were
tested for malaria using RDTs and microscopy; however
those results will not be discussed in this manuscript. Dried
blood spots (DBS) (total of 3,041) for PCR-based assays
were collected on Whatman No 1 filter papers and stored
at room temperature in individual bags with desiccants.
Sample processing and DNA extraction for molecular
tests
The DBS were transferred to the CDC Atlanta, GA,
USA, for molecular diagnosis. A complete database of
all received DBS was established upon receipt of the
samples. Each DBS was carefully examined for signs of
potential contamination and to make sure there was suf-
ficient volume of blood before DNA was extracted. Out
of the 3,041 DBS received, 52 were excluded (Figure 1).
DNA was successfully extracted from the remaining 2,989
samples using the QIAamp DNA Mini Kits (QIAGEN,
Valencia, CA, USA) as described by the manufacturer.
Briefly, three 3-mm punches of the DBS were punched
out and placed into a 1.5-mL tube for processing, accord-
ing to instructions. The DNA was eluted in 150 μL of
elution buffer, aliquoted and stored at -20°C until use.
PET-PCR assay
All samples were screened using the multiplex PET-
PCR assay as previously described [18]. Briefly, the
amplification of Plasmodium genus (forward primer:
GGCCTAACATGGCTATGACG; reverse primer: FAM-
aggcgcatagcgcctggCTGCCTTCCTTAGATGTGGTAGCT)
Figure 1 Sample processing.
Lucchi et al. Malaria Journal 2014, 13:462 Page 3 of 5
http://www.malariajournal.com/content/13/1/462or P. falciparum forward primer: (ACCCCTCGCCTG
GTGTTTTT and reverse primer: HEX-aggcgcatagcgc
ctggTCGGGCCCCAAAAATAGGAA) was performed in a
20-μL reaction containing 2X TaqMan Environmental
buffer 2.0 (Applied BioSystems, Grand Island, NY, USA),
125 nM each of forward and reverse primers except for
the P. falciparum HEX-labelled primer which was used at
a 62.5 nM. For each sample, duplicate PET-PCR reactions
were run with 2 μL of DNA template used in the PCR
reaction with the following cycling parameters: initial hot-
start at 95°C for 10 min, followed by 45 cycles of denatur-
ation at 95°C for 10 sec, annealing at 60°C for 40 sec. The
correct fluorescence channel was selected for each fluores-
cently labelled primer-set and the cycle threshold (CT)
values recorded at the end of annealing step. All assays
were performed using Agilent Mx3005pro thermocyclers
(Agilent technologies, Santa Clara, CA, USA).
Validation process of the PET-PCR assay
In real-time PCR assays, the CT value is inversely pro-
portion to the amount of DNA in a sample. Therefore,
samples with high parasite densities reach the threshold
earlier and have low CT values, whereas samples with
low parasite densities require more cycles to reach the
threshold. Conventionally, a CT value of 40 is considered
as a cut-off to score a reaction as positive and, as such, a
sample with a CT value above 40 is considered to be
negative. In order to confirm that this cut-off for the
PET-PCR assays did not miss any positive samples,
samples that produced any CT value (including CT
values above 40), were retested using a conventional gel-
based nested PCR assay [21] and a previously describedTaqMan-based real-time PCR (here after referred as
Rougemont real-time PCR) [22]. In addition, a subset
of PET-PCR negative samples (samples with a ‘no CT
value’) were randomly selected by picking every tenth
sample from the database and tested using these two
methods.
Nested 18S rRNA PCR
The nested 18S rRNA PCR assay used in this study was
used as described by Singh et al. [21]. Briefly, both pri-
mary and secondary PCR reactions were performed
using 2 μL DNA template in 25 μL total volume con-
taining 1X buffer, 2.5 mM MgCl2, 200 μM dNTPs, 200
nM primers, and 1.25 units of Taq Polymerase (New
England Biolabs, Ipswich, MA, USA). The products were
analysed for the appropriate size on a 2% agarose gel
with a positive being the identification of the correct
base-pair size.
Rougemont real-time PCR assay
A dual-labelled, probe-based, real-time PCR assay devel-
oped by Rougemont et al. [22] was included for compar-
ability with the real-time PET-PCR methodology. The
Rougemont real-time PCR is a duplex PCR, capable of
detecting the four human-infecting Plasmodium species
in a set of two simultaneous separate duplex reactions
(P. falciparum duplexed with Plasmodium vivax and
Plasmodium malariae duplexed with Plasmodium ovale).
This assay was performed as described by the authors.
Briefly, a 25-μL reaction containing 12.5 μL of TaqMan
Universal Master Mix (Life Technologies Grand Island,
NY, USA), 200 nM each of the Plasmodium specific
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specific probes was prepared. Two μL of template DNA
was used in each reaction. The assay was executed using
the following cycling conditions: an initial step at 50°C for
2 min, 95C° for 10 min, and 45 cycles of 95°C for 15 sec,
and 60°C for 1 min. A cut-off CT value of 40 was used to
indicate a positive result. All assays were performed
using the Applied Biosystems 7500 thermocyclers
(Life Technologies, Grand Island, NY, USA).
Results
Multiplex PET-PCR was performed on all 2,989 samples
(Figure 1). DNA extraction and performing the molecu-
lar tests took a dedicated team of three individuals about
five months to complete. Most of the time was spent on
DNA extraction procedure. Twelve samples had CT
values <40 for both the genus and P. falciparum primers
and were considered positive. A total of 316 samples had
a CT value >40 by PET-PCR. These samples were
retested with nested PCR and Rougemont real-time PCR
and all were negative (Figure 1) by both methods. A total
of 2,661 samples had a ‘no CT’ value by the PET-PCR
and therefore considered negative; a subset of 218 of
these negative samples were randomly selected and
retested by the nested PCR and Rougemont real-time
PCR. Rougemont real-time PCR produced the same re-
sults as PET-PCR, consistent with a previous demonstra-
tion showing equivalent performance [18]. However,
nested PCR assay found one additional positive sample
(Figure 1). The sensitivity and specificity of the PET-
PCR compared to the nested PCR as a reference test
was 92.3% (95% CI: 62.1-99.6%) and 100% (95% CI: 99.8-
100%), respectively (Table 1).
Discussion
The CT value of 11 of the 12 positive samples was be-
tween 34 and 38, and one sample had a CT value of 28.
A hundred percent concordance for these 12 samples
was found when they were tested with the Rougemont
real-time PCR and nested PCR. These tests also confirmed
that the 12 samples were positive for P. falciparum and no
other species of malaria parasites were detected. The mean
CT value of the 12 positive samples was 35.7 giving anTable 1 Comparison of the PET-PCR and the nested PCR
utilized in this study
Properties PET-PCR Nested PCR
Detection limits (parasites/μL) 3.2 ≤ 1
Species detected Genus and P. falciparum All four species
Ideal of large scale testing? Yes No
Cost ~$2.08 ~$3.2/species
Sensitivity and specificity
compared to nested PCR
92.3 and 100% N/Aestimated parasitaemia of approximately 39.8 parasites/μL.
This demonstrates that the average parasite density in
circulation in the surveyed region is low.
In the current investigation, a malaria point prevalence
of 0.4% was calculated using the PET-PCR assay. This
low level of prevalence places Haiti in a good position to
consider malaria elimination. Indeed, Haiti is among the
15 countries in the Americas that are in the malaria con-
trol phase and efforts are being mobilized to move to-
wards malaria elimination [20]. The need to use more
sensitive detection tools, such as molecular tests, in re-
gions of low malaria transmission was recently proposed
by a WHO Evidence Review Group [23], in March 2014.
Several recommendations on the use of molecular tests
in these transmission settings were put forth, including
the necessity for standard operating procedures, which
clearly define sample collection methods, preparation of
DNA from samples and the need to use an equivalent of
at least 5 μL of blood for amplification in the molecular
assay. In addition, WHO’s Evidence Review Group rec-
ommended that the molecular test have a detection limit
of at least 2 parasites/μL for it to be considered of “sub-
stantial improvement” over RDT and microscopy. The
limits of detection of the PET-PCR were reported to be
around 3.2 parasites/μL [18]. The assay, as reported, uti-
lizes 2 μL of template DNA which was determined to be
equivalent to approximately 1 μL of whole blood. Utiliz-
ing an equivalent of 5 μL whole blood, as recommended
by the WHO, will most likely improve the sensitivity of
the PET-PCR to approach or exceed 2 parasites/μL.
Real-time PCR assays, such as the PET-PCR, provide
convenient molecular tests for the screening of large
number of samples in national surveillance studies
or other large-scale malaria elimination programmes
such as mass screen-and-treat programmes. An im-
portant question remains: which molecular test should
a programme use for success? In this study, the nested
PCR detected an additional sample, most probably
with parasite density below the limits of detection of
the PET-PCR. However, while nested PCR assays may
be slightly more sensitive than most real-time PCR
assays, they are logistically not amenable to high
throughput screening: the nested PCR requires two
rounds of PCR amplification (resulting in its increased
sensitivity) and a manual post-PCR gel electrophoresis
step for visualizing results. Additionally, because the
nested PCR is not a closed system, the risk of contamin-
ation can compromise tests results. Should elimination
programmes be attempting to detect all ultra-low
parasite densities? Clearly this will depend on the pro-
gramme’s resources and the WHO’s recommendations
[23] will help guide programmes on the selection of
appropriate molecular tests to use in low transmission
settings.
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This study has demonstrated the utility of the PET-PCR
assay as a tool for high throughput screening for malaria
parasites in a country of low malaria transmission. This
technique has been transferred to Haiti National Public
Health lab for use in future malaria surveys.
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